X4 Pharmaceuticals Inc. (XFOR)
0.26
-0.01 (-4.09%)
At close: Mar 28, 2025, 3:59 PM
0.26
0.61%
Pre-market: Mar 31, 2025, 05:52 AM EDT
X4 Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | 2.56M | n/a | n/a | n/a | 3M | n/a | 3.5M | n/a | n/a | n/a |
| Cost of Revenue | 797K | 2M | 1.99M | 1.89M | n/a | 672K | 103K | 195K | 300K | 400K |
| Gross Profit | 1.76M | -2M | -1.99M | -1.89M | 3M | -672K | 3.4M | -195K | -300K | -400K |
| Operating Income | -36.4M | -107.52M | -87.57M | -85.11M | -59.87M | -51.7M | -45.88M | -36.13M | -24.35M | -14.82M |
| Interest Income | 5.77M | 4.58M | 219K | 10K | 273K | 1.2M | 809K | 214K | n/a | n/a |
| Pretax Income | -37.14M | -101.09M | -93.84M | -88.68M | -61.98M | -52.81M | -43.02M | -33.88M | -22.98M | -13.22M |
| Net Income | -37.45M | -101.17M | -93.87M | -88.7M | -62.13M | -56.6M | -43.02M | -33.88M | -22.98M | -13.22M |
| Selling & General & Admin | 61.52M | 35.51M | 27.02M | 24.7M | 20.94M | 17.64M | 18.41M | 8.01M | 6.51M | 2.12M |
| Research & Development | 81.64M | 70.02M | 61.06M | 50.65M | 41.93M | 30.16M | 30.98M | 28.13M | 17.83M | 12.71M |
| Other Expenses | -105M | n/a | -6.27M | -3.57M | -2.11M | -1.1M | -85K | -16K | 104K | -77K |
| Operating Expenses | 143.16M | 107.52M | 88.08M | 75.35M | 62.87M | 47.8M | 46.21M | 32.27M | 21.96M | 12.67M |
| Interest Expense | 8.77M | 5.78M | 3.99M | 3.64M | 2.69M | 2.15M | 1.04M | 2.08M | 2.52M | 472K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 143.96M | 107.52M | 88.08M | 75.35M | 62.87M | 47.8M | 46.21M | 32.27M | 21.96M | 12.67M |
| Income Tax | 310K | 78K | 28K | 17K | 148K | 3.8M | 3.9M | 1.87M | 2.62M | 395K |
| Shares Outstanding (Basic) | 201.06M | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459K | 343.64K | 928.01K | 928.01K |
| Shares Outstanding (Diluted) | 201.06M | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459K | 343.64K | 928.01K | 928.01K |
| EPS (Basic) | -0.19 | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 | -98.58 | -24.76 | -14.24 |
| EPS (Diluted) | -0.19 | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 | -98.58 | -24.76 | -14.24 |
| EBITDA | -36.4M | -107.1M | -87.57M | -85.11M | -58.06M | -51.7M | -45.88M | -31.6M | -20.16M | -12.35M |
| Depreciation & Amortization | 796K | 419K | 1.99M | 1.89M | 1.23M | 672K | 103K | 195K | 300K | 389K |